Nikhil K. Channabasappa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nikhil K. Channabasappa has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Shailesh Kumar Patel
Department of Veterinary Pathology, College of Veterinary Science and Animal Husbandry, NDVSU, Rewa, Madhya Pradesh, India
8 shared publications - Aditya Agrawal
Department of Veterinary Physiology and Biochemistry, College of Veterinary Science and Animal Husbandry, NDVSU, Rewa, Madhya Pradesh, India
6 shared publications - Ankush Kiran Niranjan
Department of Veterinary Microbiology
6 shared publications - Jigyasa Rana
Department of Veterinary Anatomy, Faculty of Veterinary and Animal Sciences, RGSC, BHU, Barkachha, Mirzapur, Uttar Pradesh, India
6 shared publications - Talha Bin Emran
Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh
6 shared publications Aditya Agrawal
Department of Veterinary Physiology and Biochemistry
5 shared publications
Latest Publications
- Open Access
- 26 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (1) , 542-547
Emergence of Chandipura viral encephalitis in India: a strategic approach to combat a fatal viral epidemic
Vector-borne viral encephalitis is currently a significant public health concern worldwide. Factors such as climate change, urbanization, rapid land development, globalization of trade, increased intercontinental travel, and ecological disruptions are contributing to the emergence of many viral diseases. Chandipura virus encephalitis (CHPVE) is one of the prominent emerging viral diseases, quickly becoming a serious health threat. CHPVE is an acute, febrile viral illness with a high-case fatality rate. The disease was first identified in 1965 in Chandipura, Nagpur district of Maharashtra, during an outbreak of mosquito-borne diseases such as Dengue and Chikungunya. Initially, the outbreak was confined to Maharashtra, but it later spread to neighbouring states like Gujarat, Madhya Pradesh, Andhra Pradesh, and Chhattisgarh. Two decades after its initial case in Maharashtra, the disease has now been spread to other countries, including Nigeria, Senegal, West Africa, and Sri Lanka. As the name suggests, CHPVE is caused by the Chandipura virus (CHPV), belonging to the Vesiculovirus genus of the Rhabdoviridae family, responsible for the incidence of well-known neurotrophic disease, i.e., Rabies.
- 26 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (1) , 542-547
Open AccessEmergence of Chandipura viral encephalitis in India: a strategic approach to combat a fatal viral epidemic
Vector-borne viral encephalitis is currently a significant public health concern worldwide. Factors such as climate change, urbanization, rapid land development, globalization of trade, increased intercontinental travel, and ecological disruptions are contributing to the emergence of many viral diseases. Chandipura virus encephalitis (CHPVE) is one of the prominent emerging viral diseases, quickly becoming a serious health threat. CHPVE is an acute, febrile viral illness with a high-case fatality rate. The disease was first identified in 1965 in Chandipura, Nagpur district of Maharashtra, during an outbreak of mosquito-borne diseases such as Dengue and Chikungunya. Initially, the outbreak was confined to Maharashtra, but it later spread to neighbouring states like Gujarat, Madhya Pradesh, Andhra Pradesh, and Chhattisgarh. Two decades after its initial case in Maharashtra, the disease has now been spread to other countries, including Nigeria, Senegal, West Africa, and Sri Lanka. As the name suggests, CHPVE is caused by the Chandipura virus (CHPV), belonging to the Vesiculovirus genus of the Rhabdoviridae family, responsible for the incidence of well-known neurotrophic disease, i.e., Rabies.
- Open Access
- 18 July 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (8) , 4710-4712
Unveiling the link between Oropouche virus and Guillain-Barré syndrome: a growing public health concern
- 18 July 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (8) , 4710-4712
Open AccessUnveiling the link between Oropouche virus and Guillain-Barré syndrome: a growing public health concern
- Open Access
- 1 November 2024
- Published by Wolters Kluwer Health in International Journal of Surgery: Global Health
- Vol. 7 (6)
Battling Kyasanur forest disease: the race for robust and long-lasting Kyasanur forest disease vaccine
- 1 November 2024
- Published by Wolters Kluwer Health in International Journal of Surgery: Global Health
- Vol. 7 (6)
Open AccessBattling Kyasanur forest disease: the race for robust and long-lasting Kyasanur forest disease vaccine
- Open Access
- 1 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (5) , 2243-2246
Mpox vaccination in global perspective: priorities and challenges
After the global panic created by COVID-19, the monkeypox (Mpox) virus emerged as a new challenge for the world population. As of 19 January 2023, a total of 84,733 cases across 110 countries/territories including 80 deaths has been reported. The virus has been transmitted to nonendemic countries in a short span of 6 months warranting WHO to declare Mpox, a Public Health Emergency of International Concern on 23 July 2022. As the Mpox virus is crossing geographical boundaries without established transmission patterns, there is an urgent need for new scientific strategies from global researchers to contain it before turning into the next pandemic. The control of Mpox outbreaks primarily relies on various public health measures such as proper surveillance, contact tracing, rapid diagnosis, isolation and care of patients, and vaccination. At present, there are three vaccines viz. ACAM2000, MVABN, and LC16 are in consideration and have been approved in several jurisdictions for ongoing Mpox outbreak. Prioritization of individuals along with the production of specific Mpox vaccine is need of the hour to meet out the global demand of Mpox vaccination.
- 1 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (5) , 2243-2246
Open AccessMpox vaccination in global perspective: priorities and challenges
After the global panic created by COVID-19, the monkeypox (Mpox) virus emerged as a new challenge for the world population. As of 19 January 2023, a total of 84,733 cases across 110 countries/territories including 80 deaths has been reported. The virus has been transmitted to nonendemic countries in a short span of 6 months warranting WHO to declare Mpox, a Public Health Emergency of International Concern on 23 July 2022. As the Mpox virus is crossing geographical boundaries without established transmission patterns, there is an urgent need for new scientific strategies from global researchers to contain it before turning into the next pandemic. The control of Mpox outbreaks primarily relies on various public health measures such as proper surveillance, contact tracing, rapid diagnosis, isolation and care of patients, and vaccination. At present, there are three vaccines viz. ACAM2000, MVABN, and LC16 are in consideration and have been approved in several jurisdictions for ongoing Mpox outbreak. Prioritization of individuals along with the production of specific Mpox vaccine is need of the hour to meet out the global demand of Mpox vaccination.
- Open Access
- 1 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1321-1322
Resurgence of cholera in the COVID-19 era: a global health concern
- 1 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1321-1322
Open AccessResurgence of cholera in the COVID-19 era: a global health concern
- Open Access
- 1 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1323-1324
Mpox and the need for improved diagnostics – correspondence
An abstract is unavailable. This article is available as a PDF only.
- 1 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1323-1324
Open AccessMpox and the need for improved diagnostics – correspondence
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 1 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1325-1326
Spillover of viruses and global concern: is simian haemorrhagic fever virus next in queue? – correspondence
An abstract is unavailable. This article is available as a PDF only.
- 1 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1325-1326
Open AccessSpillover of viruses and global concern: is simian haemorrhagic fever virus next in queue? – correspondence
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 25 March 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1319-1320
Vitamin D in therapy and management: armor against COVID-19 – correspondence
An abstract is unavailable. This article is available as a PDF only.
- 25 March 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1319-1320
Open AccessVitamin D in therapy and management: armor against COVID-19 – correspondence
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 13 March 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (4) , 1054-1055
SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects – correspondence
- 13 March 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (4) , 1054-1055
Open AccessSARS-CoV-2 variant omicron XBB.1.5: challenges and prospects – correspondence
- Open Access
- 2 March 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. Publish Ah
Sudan ebolavirus (SUDV) outbreak in Uganda: transmission, risk assessment, prevention, and mitigation strategies – correspondence
An abstract is unavailable. This article is available as a PDF only.
- 2 March 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. Publish Ah
Open AccessSudan ebolavirus (SUDV) outbreak in Uganda: transmission, risk assessment, prevention, and mitigation strategies – correspondence
An abstract is unavailable. This article is available as a PDF only.